SCHEMBL6388568

SCHEMBL6388568

CCc1cc(S(=O)(=O)O)c2cccc3c2c1C(=O)OC3=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 6/20 0.39
▸ KDM4E B2RXH2 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ HPGD P15428 4/20 0.34
▸ HTT P42858 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ AURKB Q96GD4 2/20 0.34
▸ PGAM1 P18669 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ BRD4 O60885 4/20 0.32
▸ CDC7 O00311 1/20 0.32
▸ EEF2K O00418 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395017 0.91 MAPKAPK2 (0.38) TYMSKDM4EALDH1A1HPGDHTT
SCHEMBL6393866 0.89 ELANE (0.39) TYMSKDM4EHPGDHTTBRD4
SCHEMBL6389534 0.88 ELANE (0.38) TYMSCYP1A2AURKBPGAM1AURKA
SCHEMBL6390921 0.84 TYMS (0.39) TYMSKDM4ESMN1; SMN2AURKBPGAM1
SCHEMBL6390026 0.83 TYMS (0.35) TYMSKDM4EALDH1A1HPGDHTT
SCHEMBL6390741 0.82 TYMS (0.38) TYMSAURKBPGAM1AURKACES1
SCHEMBL6394517 0.81 TYMS (0.37) TYMSKDM4EALDH1A1HPGDCYP1A2
SCHEMBL6395177 0.79 TYMS (0.40) TYMSKDM4EHPGDHTTSMN1; SMN2
SCHEMBL1517967 0.78 CYP1B1 (0.41) TYMSKDM4EALDH1A1MEN1KMT2A
SCHEMBL6388290 0.77 ELANE (0.37) TYMSKDM4EALDH1A1HPGDAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 — — US disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 TYMS 4742/4885KDM4E 1906/4885ALDH1A1 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback